Senior Lecturer and Honorary Consultant in Medical Oncology
0161 446 3391
0161 446 3299
BMBCh, MSc Oncology, MRCP, PhD
Medical oncology; treatment of ovarian and endometrial malignancies; early phase clinical trials
Christie and Manchester Cancer network lead for gynaecological cancer clinical trials; research member of Christie Research Strategy Group
The University of Manchester Women’s Cancer Centre lead; member of the University College London Cancer Trials Unit trials steering committee; member of the National Cancer Research Institute’s (NCRI) gynaecological cancers clinical studies group; member of the ovarian and endometrial subgroups of the Scottish Gynaecological Cancers Clinical Trials Group
Dr Clamp is the International Chief Investigator for the Medical Research Council/ Cancer Research UK ICON8 phase III clinical trials programme, evaluating weekly chemotherapy fractionation in ovarian cancer. He held the Higher Education Funding Council for England (HEFCE) clinical senior lecturer award 2007-2012. Dr Clamp studied medicine at Cambridge and Oxford Universities. He undertook his medical oncology training at The Christie and was awarded a PhD for research on the anti-angiogenic protein fragment, endostatin.
He specialises in the drug treatment of women with ovarian and endometrial cancers and leads The Christie gynaecological cancers clinical trials team. Nationally, he is a member of the NCRI gynaecological cancer clinical studies group and heads their flagship trials programme in ovarian cancer, ICON8. He also has a special interest in the development of biomarkers of efficacy for anti-angiogenic treatments and is a member of the translational angiogenesis group at The Christie/The University of Manchester.